|
|
Previous Article | Table of Contents | Next Article 
Identification of Increased Protein Tyrosine Phosphatase Activity in Polycythemia Vera Erythroid Progenitor Cells
Xingwei Sui,
Sanford B. Krantz, and
Zhizhuang Zhao
From the Hematology Division, Department of Medicine, and the Department of Veterans Affairs Medical Center, Vanderbilt University, Nashville, TN.
Polycythemia vera (PV) is a clonal hematologic disease characterized by hyperplasia of the three major bone marrow lineages. PV erythroid progenitor cells display hypersensitivity to several growth factors, which might be caused by an abnormality of tyrosine phosphorylation. In the present study, we have investigated protein tyrosine phosphatase (PTP) activity in highly purified erythroid progenitor cells and found that the total PTP activity in the PV cells was twofold to threefold higher than that in normal cells. Protein separation on anion-exchange and gel-filtration columns showed that the increased activity was due to a major PTP eluted at approximately 170 kD. This enzyme was sensitive to PTP inhibitors and it did not cross-react with antibodies to SHP-1, SHP-2, or CD45. Subcellular fractionation showed that the PTP localized with the membrane fraction, where its activity was increased by threefold in PV erythroid progenitors when compared with normal cells. As the erythroid progenitors progressively matured, activity of the PTP declined rapidly in the normal cells but at a much slower rate in the PV cells. These studies suggest that a potentially novel membrane or membrane-associated PTP, representing a major PTP activity, may have an important role in proliferation and/or survival of human erythroid progenitors and that its hyperactivation in PV erythroid progenitors might be responsible for the increased erythropoiesis in PV patients.
Blood, Vol. 90 No. 2 (July 15), 1997:
pp. 651-657
© 1997 by The American Society of Hematology.

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
R. Zhao, S. Xing, Z. Li, X. Fu, Q. Li, S. B. Krantz, and Z. J. Zhao
Identification of an Acquired JAK2 Mutation in Polycythemia Vera
J. Biol. Chem.,
June 17, 2005;
280(24):
22788 - 22792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-j. Xu, X. Sui, R. Zhao, C. Dai, S. B. Krantz, and Z. J. Zhao
PTP-MEG2 is activated in polycythemia vera erythroid progenitor cells and is required for growth and expansion of erythroid cells
Blood,
December 15, 2003;
102(13):
4354 - 4360.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tefferi
Polycythemia Vera: A Comprehensive Review and Clinical Recommendations
Mayo Clin. Proc.,
February 1, 2003;
78(2):
174 - 194.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
J. L. Spivak
Polycythemia vera: myths, mechanisms, and management
Blood,
December 15, 2002;
100(13):
4272 - 4290.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Dai and S. B. Krantz
Increased expression of the INK4a/ARF locus in polycythemia vera
Blood,
June 1, 2001;
97(11):
3424 - 3432.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. C. Pearson, M. Messinezy, N. Westwood, A. R. Green, A. J. Bench, A. R. Green, B. J.P. Huntly, E. P. Nacheva, T. Barbui, and G. Finazzi
A Polycythemia Vera Update: Diagnosis, Pathobiology, and Treatment
Hematology,
January 1, 2000;
2000(1):
51 - 68.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
X. Sui, S. B. Krantz, M. You, and Z. Zhao
Synergistic Activation of MAP Kinase (ERK1/2) by Erythropoietin and Stem Cell Factor Is Essential for Expanded Erythropoiesis
Blood,
August 15, 1998;
92(4):
1142 - 1149.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Oda, K. Sawada, B. J. Druker, K. Ozaki, H. Takano, K. Koizumi, Y. Fukada, M. Handa, T. Koike, and Y. Ikeda
Erythropoietin Induces Tyrosine Phosphorylation of Jak2, STAT5A, and STAT5B in Primary Cultured Human Erythroid Precursors
Blood,
July 15, 1998;
92(2):
443 - 451.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M.-j. Xu, R. Zhao, and Z. J. Zhao
Identification and Characterization of Leukocyte-associated Ig-like Receptor-1 as a Major Anchor Protein of Tyrosine Phosphatase SHP-1 in Hematopoietic Cells
J. Biol. Chem.,
June 2, 2000;
275(23):
17440 - 17446.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|
|